Efficacy and Tolerability of Meloxicam, a COX-2 Preferential Nonsteroidal Anti-Inflammatory Drug: A Review

By Del Tacca M.   Colucci R.   Fornai M.   Blandizzi C.  

Clinical Drug Investigation, Vol. 22, Iss. 12, 2002-01 ,pp. : 799-818

Adis International

Access to resources Recommend Favorite

Colon Cancer: A Role for Cyclo-oxygenase-2-Specific Nonsteroidal Anti-Inflammatory Drugs

By Reddy B.S.   Rao C.V.  

Drugs & Aging, Vol. 16, Iss. 5, 2000-05 ,pp. : 329-334

Adis International

Access to resources Recommend Favorite

The Effectiveness of a Weak Opioid Medication versus a Cyclo-oxygenase-2 (COX-2) Selective Non-steroidal Anti-inflammatory Drug in Treating Flare-up of Chronic Low-back Pain: Results from Two Randomized, Double-blind, 6-week Studies

By O'Donnell JB   Ekman EF   Spalding WM   Bhadra P   McCabe D   Berger MF  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1789-1802

Field House Publishing

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Davies N.M.  

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite

An anti-inflammatory ditriazine inhibiting leukocyte functions and expression of inducible nitric oxide synthase and cyclo-oxygenase-2

By Rioja I.   Ubeda A.   Terencio M.C.   Guillen I.   Riguera R.   Quintela J.M.   Peinador C.   Gonzalez L.M.   Alcaraz M.J.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 207-217

Elsevier

Access to resources Recommend Favorite